Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. What specific risks should consumers be informed about? Specifically, the agency fears that.

CBD 103

CBD Safety Topical Food 103

Veriheal

OCTOBER 20, 2021

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy. A Magical Future.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Specific therapy indication. Access Psychiatry deal headline, upfront, milestone and royalty data. Advanced Cooling Therapy.

Access 40

Access Data Pharmaceutical Research and Development 40

The Joint Blog

NOVEMBER 4, 2019

The study found that 58% of physicians agree that “medical cannabis was a legitimate medical therapy.” ” However, as noted by NORML, around half of respondents “expressed discomfort in talking to their patients about medical cannabis options, a finding that is also consistent with prior data. A majority (>?50%)

Therapy 42

Therapy Clinical Trials Conditions Patients 42

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. RoC also works to increase patients’ access to medical cannabis by helping U.S.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

JANUARY 4, 2021

The feds are looking for information on how cannabis and/or Kratom might treat pain. The AHRQ is hoping to gather information on four specific questions in particular. Medicinal cannabinoid therapies are saving and changing lives for people across America and around the world.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

TheAnswerPage

JANUARY 11, 2022

In fact, from pediatricians to geriatricians, I cannot think of any medical practitioner that does not need to be well informed about the endocannabinoid system and cannabis-based therapeutics. Who monitors their health and the long-term effects of the marijuana therapy?

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

SEPTEMBER 28, 2021

“The TGA has approved the use of MDMA and Psilocybin to treat mental illness in Australia by qualified medical professionals under a special access scheme. Participant Information Sheet. My ANIP host organisation (Johnathan Davis MLA’s office) may also use the data. If you withdraw no data from your response will be saved.

Therapy 52

Therapy Medicine Data Collective 52

Cannabis Law Report

AUGUST 2, 2021

The diversified venture fund is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape the future of psychiatry and fields beyond. Innovative psychedelic-based and adjacent therapies are poised to shape the future of psychiatry and fields beyond.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Cannabis Law Report

JUNE 29, 2021

Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 121

Research and Development Data THC Clinical Trials 121

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. For more information, visit [link]. Eric Rahn, Managing Director.

Medicine 75

Medicine Business Research and Development Chronic Pain 75

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

The Cannigma

FEBRUARY 2, 2021

Patients can also access CBD products without a prescription through local pharmacies. We also lack information about the extent to which the PD community is informed about medicinal cannabis and whether they have tried cannabis and, if so, with what result.”.

Patients 97

Patients Clinical Trials Research and Development Treatment 97

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. federal law, from which point, informed choices can be made about the use of cannabis and cannabinoids.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

JUNE 17, 2021

Silo Wellness is a publicly traded company on the CSE with a consumer-facing platform for the sale of functional mushroom products, psilocybin mushroom production in Jamaica, and the facilitation of psychedelic wellness retreats in both Jamaica and Oregon that incorporate a variety of psychedelic-augmented therapies.

Research and Development 75

Research and Development Therapy Access Media 75

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. ADDITIONAL INFORMATION. Accessed August 2021.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. Availability of other information about COMPASS Pathways.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

JULY 6, 2021

Johnson, DSc, MD, MPhil, FRCPsych said, “I am pleased to join the Ehave Medical Advisory Board and look forward to working towards bringing psychedelic-assisted therapies to patients experiencing substance use issues. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

SpeedWeed

SEPTEMBER 17, 2021

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Veriheal

APRIL 24, 2023

However, despite the mounting data supporting their efficacy, the precise mechanism of action for psychedelics remains a mystery. They play a crucial role in transmitting information throughout the body, helping us to perceive, think, and interact with our environment. What Are Neurons?

Research and Development 89

Research and Development Treatment Conditions Therapy 89

Cannabis Law Report

JULY 29, 2021

Information. The company posts important information and updates through weekly videos from the official company YouTube channel [link]. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights.

Research and Development 81

Research and Development Conditions Data Patients 81

Puff Puff Post

FEBRUARY 4, 2019

Physicians who treat young people now face a series of dilemmas: The anti-smoking therapies on the market — such as nicotine patches and gums — are not approved for children, due to lack of testing or ineffective results. Quitting smoking is notoriously difficult, even for adults with access to various aids and programs.

Vaping 101

Vaping Therapy Programs Advocacy 101

Cannabis Law Report

AUGUST 3, 2021

ADCL’s solution includes the use of subcontractor CLEARED4’s health verification platform for appointments, sample tracking, and value-add services of campus access management. Visit adnas.com for more information. As prime contractor, ADCL will also provide on-site staffing and sample transport and logistics. Join our mailing list.

Clinical Trials 81

Clinical Trials Therapy Collective Research and Development 81

Cannabis Law Report

SEPTEMBER 2, 2021

ADCL will serve as prime contractor with subcontractor CLEARED4’s health verification platform to be used for appointments, sample tracking, reporting, program management, and mobile access pass visibility. Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Clinical Trials 76

Clinical Trials Research and Development Therapy Collective 76

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Info

MARCH 2, 2019

Cannabis is being viewed as a potential treatment for epileptic seizures and large success has been witnessed so far, triggering a large movement of people and organisations who are in favour of its access and medicinal use. ” CBD may be easier for patients to access when they opt to start treatment with medical cannabis.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

NOVEMBER 22, 2019

“Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. “MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking.” For more information visit: [link]. 561-627-9455.

DEA 51

DEA Clinical Trials THC Research and Development 51

CannaMD

DECEMBER 9, 2020

The authors also list a range of additional conditions for which there are possible benefits of cannabis therapies, including opiate withdraw, dystonia, glaucoma, Alzheimer’s disease, anxiety and depression, anti-tumor effects, inflammatory bowel diseases, Parkinson’s disease, and sleep disorders. for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

MAY 13, 2019

Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. In nearly every jurisdiction where medicinal cannabis is legal, at least one medical professional is required to sign off for a person to access it. Copyright: © 2019 Gardiner et al.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

MMJ Recs

JUNE 15, 2022

There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. Located in Midtown, this clinic provides patients with easy access to their doctors – you can text, live chat, or book online for same-day appointments. Ainsworth Institute of Pain Management.

Patients 52

Patients Treatment Clinical Trials Therapy 52

United Patients Group

AUGUST 16, 2023

Accessibility and Inclusivity Building an inclusive and accessible workplace is the first step in improving the daily lives of people with disabilities. Accessibility involves digital areas and data in addition to physical infrastructure.

Advocacy 52

Advocacy Education Access Environment 52

Cannabis Law Report

NOVEMBER 5, 2021

Negative testing results yield a ‘green pass’ via CLEARED4 that is texted to the employee’s smartphone that authorizes access to corporate facilities. ’ Positive testing results yield a ‘red pass’ to the employee that should deny access to corporate facilities until said employee tests negative. Dr. James A.

Compliance 40

Compliance Compliance Research and Development Therapy 40

Greencamp

APRIL 23, 2019

MS is an autoimmune disease in which the immune system attacks myelin—a fatty substance that envelops nerve cells and fibers, allowing information exchange. These therapies usually include corticosteroids or plasma exchange, but they only slow down the progression of MS. So, what do we know about multiple sclerosis?

Research and Development 94

Research and Development Strains Patients Treatment 94

CannaMD

MAY 14, 2020

Florida’s medical marijuana community may soon have access to edible forms of cannabis. Data from Colorado, which was among the first states to legalize marijuana, indicates that edible cannabis-infused products account for some 45% of all cannabis sales. Why Do People Like Marijuana Edibles?

Edibles 105

Edibles Marijuana THC Vaping 105